×

New AI partnership targets earlier MS diagnosis using circular RNA

Decode Health and Circular Genomics are partnering to use artificial intelligence (AI) to identify patterns in circular RNA — stable genetic molecules able to signal disease — that may help diagnose multiple sclerosis (MS) earlier and monitor its progression over time. The collaboration brings together…

Ocrevus (ocrelizumab) for multiple sclerosis

Ocrevus (ocrelizumab) is an infusion therapy approved to treat adults with relapsing forms of MS and primary progressive MS. Administered via an intravenous infusion, the treatment is used to reduce the frequency of relapses, lower the number of lesions, and slow disability progression. The post…

Privosegtor optic neuritis clinical trial design gains FDA agreement

The U.S. Food and Drug Administration (FDA) has formally agreed that the design and planned analysis of an upcoming Phase 3 trial testing privosegtor in people with optic neuritis could support a future application seeking the therapy’s approval if the trial succeeds. Optic neuritis, or…